Nearly 50 percent of colorectal cancer survivors have continued pain interference

the ONA take:

According to a recent study published in the journal Pain Medicine, researchers from the University of Alabama at Birmingham have found that almost half of colorectal cancer survivors with pain interference during the initial phase of care have continued pain interference after treatment.

For the study, researchers analyzed survey results from participants with colorectal cancer of the Cancer Care Outcomes Research and Surveillance Consortium during the initial phase of care and follow-up.

They identified 2,961 patients during the initial phase and 2,303 patients during follow-up. Results showed that at baseline, 24.7% of participants reported moderate and high pain interference compared with 23.7% during follow-up.

For 46% of participants with baseline pain interference, pain interference was either the same or worse at follow-up. 

Researchers found that chemotherapy, comorbidities, depression, female gender, and radiation were associated with moderate and high pain interference at the time of diagnosis and during follow-up. On the other hand, older age was associated with improved pain interference.

The study also showed that those pulmonary disease or heart failure comorbidities had equivalent or increasing pain interference at follow-up.

Nearly 50% of colorectal cancer survivors have continued pain interference
Almost half of colorectal cancer survivors with pain interference during the initial phase of care have continued pain.
Almost half of colorectal cancer (CRC) survivors with pain interference (PI) during the initial phase of care have continued PI post-treatment, according to a study published online March 20 in Pain Medicine.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs